These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9694946)

  • 41. Stress-induced suppression of the immune system after withdrawal from chronic cocaine.
    Avila AH; Morgan CA; Bayer BM
    J Pharmacol Exp Ther; 2003 Apr; 305(1):290-7. PubMed ID: 12649381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Search for immunomodulatory effects of blood transfusion in gastric cancer patients: flow cytometry of Th1/Th2 cells in peripheral blood.
    Sun CF; Hsieh YY; Ngan KW; Wang WT
    Ann Clin Lab Sci; 2001 Apr; 31(2):171-8. PubMed ID: 11337907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain function of heroin addicts after withdrawal.
    Wang X; Zhou X; Liao Y; Tang J; Liu T; Hao W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 36(8):733-8. PubMed ID: 21937798
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
    Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
    J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical effect of dynorphin on heroin addicts.
    Uneklabh T; Sintavanarong P; Wessagowit V; Lukanapichonchut L
    J Med Assoc Thai; 1995 Oct; 78(10):509-16. PubMed ID: 8576656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular parameters of heroin-withdrawn addicts treated with guanfacine.
    Rubio G; Alguacil LF; Alamo C; López-Muñoz F; Pascual J; López-Trabada JR
    Methods Find Exp Clin Pharmacol; 1997 Apr; 19(3):189-92. PubMed ID: 9203168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The combination of tizanidine markedly improves the treatment with dextromethorphan of heroin addicted outpatients.
    Koyuncuoglu H
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):13-9. PubMed ID: 7711985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determining what heroin means to heroin addicts.
    Tokar JT; Brunse AJ; Stefflre VJ; Sodergren JA; Napior DA
    Dis Nerv Syst; 1975 Feb; 36(2):77-81. PubMed ID: 1116419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunological parameters in aging: studies on natural immunomodulatory and immunoprotective substances.
    Franceschi C; Cossarizza A; Troiano L; Salati R; Monti D
    Int J Clin Pharmacol Res; 1990; 10(1-2):53-7. PubMed ID: 2387663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical assessment of physical dependence potential of dihydroetorphine hydrochloride (DHE)].
    Ge Y; Li M; Sun WL; Cai ZJ
    Yao Xue Xue Bao; 1994; 29(4):256-60. PubMed ID: 7976340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levels of opioid physical dependence in heroin addicts.
    Kanof PD; Aronson MJ; Ness R; Cochrane KJ; Horvath TB; Handelsman L
    Drug Alcohol Depend; 1991 May; 27(3):253-62. PubMed ID: 1884668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opiate withdrawal and electro-stimulation. Double blind experiments.
    Ellison F; Ellison W; Daulouede JP; Daubech JF; Pautrizel B; Bourgeois M; Tignol J
    Encephale; 1987; 13(4):225-9. PubMed ID: 3311708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Changes in several immunological parameters and the presence of anti-HTLV III antibodies in drug addicts].
    Bai P; Brugo MA; Minora T; Pedretti D; Stringhetti M; Confalonieri F
    Boll Ist Sieroter Milan; 1986; 65(3):216-29. PubMed ID: 3490858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy.
    Barcellini W; Meroni PL; Frasca D; Sguotti C; Borghi MO; Uberti-Foppa C; Buzzetti P; Lazzarin A; Doria G; Moroni M
    Clin Exp Immunol; 1987 Mar; 67(3):537-43. PubMed ID: 3301099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self-detoxification by opiate addicts. A preliminary investigation.
    Gossop M; Battersby M; Strang J
    Br J Psychiatry; 1991 Aug; 159():208-12. PubMed ID: 1663410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myocardial decompensation in heroin addicts.
    Chowdhury AN; Das J
    J Assoc Physicians India; 1993 Mar; 41(3):180. PubMed ID: 8226609
    [No Abstract]   [Full Text] [Related]  

  • 57. [Guidelines and criteria concerning the admission of heroin addicts to the general hospital].
    Camí Morell J; de Torres Sanahuja S; San Molina L
    Med Clin (Barc); 1984 Feb; 82(7):327-31. PubMed ID: 6371401
    [No Abstract]   [Full Text] [Related]  

  • 58. [The effect of withdrawal on humoral and cellular immune changes in alcoholic hepatopathy].
    Banciu T; Arcan P; Suşan L; Ocică I; Sorian E
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(4):363-8. PubMed ID: 2573946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppression of morphine abstinence in heroin addicts by beta-endorphin.
    Su CY; Lin CS; Peng C; Cheng CS; Loh HH; Li CH; Way EL
    Adv Biochem Psychopharmacol; 1980; 22():503-9. PubMed ID: 7395604
    [No Abstract]   [Full Text] [Related]  

  • 60. Altered T-lymphocyte subsets in hospitalized intravenous drug abusers.
    Layon J; Idris A; Warzynski M; Sherer R; Brauner D; Patch O; McCulley D; Orris P
    Arch Intern Med; 1984 Jul; 144(7):1376-80. PubMed ID: 6610400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.